Meyaard L, van der Vuurst de Vries A R, de Ruiter T, Lanier L L, Phillips J H, Clevers H
Department of Immunology, University Medical Center, 3584 CX Utrecht, Netherlands.
J Exp Med. 2001 Jul 2;194(1):107-12. doi: 10.1084/jem.194.1.107.
Human leukocyte-associated immunoglobulin-like receptor (LAIR)-1 is expressed on many cells of the immune system and is predicted to mediate inhibitory functions based on the presence of immunoreceptor tyrosine-based inhibitory motifs (ITIMs) in its cytoplasmic domain. Although the role of LAIR-1 in the regulation of immune responses in vivo is unknown, LAIR-1 cross-linking by monoclonal antibody inhibits various immune cell functions in vitro. Here, we identify the colon carcinoma-associated epithelial cellular adhesion molecule (Ep-CAM) as a ligand for LAIR-1 and LAIR-2, a related soluble LAIR-1 family member. Ep-CAM interacts with the LAIR molecules through its first epidermal growth factor domain; Ep-CAM--specific antibodies can abrogate the binding. Intraepithelial T lymphocytes express LAIR-1 and thus may interact with Ep-CAM present on human intestinal epithelium. We propose that LAIR-1--Ep-CAM interaction may contribute to mucosal tolerance and that LAIR-2 possibly modulates this function.
人类白细胞相关免疫球蛋白样受体(LAIR)-1在免疫系统的许多细胞上表达,基于其胞质结构域中存在基于免疫受体酪氨酸的抑制基序(ITIM),预计其介导抑制功能。尽管LAIR-1在体内免疫反应调节中的作用尚不清楚,但单克隆抗体交联LAIR-1可在体外抑制多种免疫细胞功能。在此,我们鉴定出结肠癌相关上皮细胞黏附分子(Ep-CAM)是LAIR-1和LAIR-2(一种相关的可溶性LAIR-1家族成员)的配体。Ep-CAM通过其第一个表皮生长因子结构域与LAIR分子相互作用;Ep-CAM特异性抗体可消除这种结合。上皮内T淋巴细胞表达LAIR-1,因此可能与人肠上皮细胞上存在的Ep-CAM相互作用。我们提出,LAIR-1-Ep-CAM相互作用可能有助于黏膜耐受,并且LAIR-2可能调节这种功能。